{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13255",
      "entity_text" : "mGluR1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P41594",
      "entity_text" : "mGluR5",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the present study, a selective mGluR5 agonist (R, S)-2-chloro-5-hydroxyphenylglycine (CHPG), which does not activate mGluR1, was used to examine the specific contribution of mGluR5 to neuronal damage after TBI.",
  "reading_complete" : "2020-08-02T15:22:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:20:37Z",
  "trigger" : "activate",
  "evidence" : [ "mGluR5 agonist (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG), which does not activate mGluR1" ],
  "pmc_id" : "3577346",
  "score" : 0
}